Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-01-04 @ 12:35 PM
Study NCT ID:
NCT03836768
Status:
COMPLETED
Last Update Posted:
2023-02-15
First Post:
2019-01-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma
Sponsor:
Zhejiang DTRM Biopharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DTRM_DTRMWXHS-12_004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None